Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response to Supplement and Placebo in GERD

NCT01915173 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01915173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response to Supplement and Placebo in GERD
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2013
Completion date
April 30, 2014
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyspepsia, gastroesophageal reflux disease (gerd), heartburn